CJC-1295 No DAC 5mg + Ipamorelin 5mg Pen (Copy)
Rp2,900,000.00 – Rp3,500,000.00Price range: Rp2,900,000.00 through Rp3,500,000.00 ~$175.76–$212.12
Explore the Atlas Longevity CJC-1295 No DAC + Ipamorelin 20mg Peptide Pen, an experimental dual-peptide formulation combining two compounds investigated in growth hormone and endocrine signalling research.
Each pre-mixed cartridge is labelled as containing:
- CJC-1295 No DAC: 10mg
- Ipamorelin: 10mg
- Total Peptide Content: 20mg
- Ingredient Ratio: 1:1 by mass
- Cartridge Volume: 3mL
- Total Pen Units: 300
- Dial Range: 1–60 units
- Format: Pre-mixed peptide pen
CJC-1295 No DAC is commonly used as a commercial name for a modified GRF(1–29) peptide, while ipamorelin is an experimental growth hormone secretagogue.
For laboratory research only. Not approved for human administration.
- COA Verified
- Same-Day Dispatch
- Ships from Bali
- SSL Secure
CJC-1295 No DAC + Ipamorelin 20mg Peptide Pen Bali
Dual Growth Hormone Signalling Research Blend
The Atlas Longevity CJC-1295 No DAC 10mg + Ipamorelin 10mg Blend combines two experimental peptides associated with different growth hormone signalling pathways.
CJC-1295 No DAC is commonly described as a growth hormone-releasing hormone analogue, while ipamorelin acts through the growth hormone secretagogue receptor.
Although these compounds have different mechanisms, the safety and effectiveness of this specific combined formulation have not been established through adequate human clinical trials.
What’s Inside the 20mg Blend?
| Ingredient | Labelled Quantity | Research Focus |
|---|---|---|
| CJC-1295 No DAC | 10mg | GHRH receptor signalling |
| Ipamorelin | 10mg | Growth hormone secretagogue receptor signalling |
| Total | 20mg | Experimental endocrine research |
What Is CJC-1295 No DAC?
CJC-1295 No DAC is a commercial term commonly used for modified GRF(1–29), a peptide associated with growth hormone-releasing hormone research.
It is important to distinguish this compound from CJC-1295 with DAC, which has a different molecular structure and pharmacokinetic profile.
Experimental research has investigated GHRH-related peptides in relation to:
- Growth hormone release
- Pituitary signalling
- GHRH receptor activity
- Endocrine regulation
- IGF-1-associated pathways
Research findings involving CJC-1295 with DAC should not automatically be attributed to products labelled CJC-1295 No DAC.
What Is Ipamorelin?
Ipamorelin is an experimental peptide that acts as an agonist at the growth hormone secretagogue receptor, GHS-R1a.
Research has investigated its involvement in:
- Growth hormone secretagogue activity
- Ghrelin receptor signalling
- Pituitary hormone responses
- Endocrine regulation
- Growth hormone pulse dynamics
Ipamorelin is not an established approved treatment for muscle growth, fat loss, anti-ageing or recovery.
Why Are CJC-1295 No DAC and Ipamorelin Studied Together?
The two peptides are associated with different receptors involved in growth hormone regulation.
- CJC-1295 No DAC: GHRH-related receptor signalling
- Ipamorelin: GHS-R1a receptor signalling
This makes the combination relevant to experimental research involving distinct endocrine pathways.
However, combining the two peptides does not establish superior effectiveness, safety or clinical benefits.
CJC-1295 No DAC vs Ipamorelin
| Feature | CJC-1295 No DAC | Ipamorelin |
|---|---|---|
| Peptide Class | GHRH-related analogue | Growth hormone secretagogue |
| Primary Receptor | GHRH receptor | GHS-R1a |
| Research Focus | Pituitary GH signalling | Ghrelin receptor-mediated GH signalling |
| Content in Pen | 10mg | 10mg |
CJC-1295 No DAC vs CJC-1295 With DAC
These are different peptide formulations.
CJC-1295 with DAC contains a drug affinity complex designed to alter its pharmacokinetic behaviour.
Products marketed as CJC-1295 No DAC generally refer to modified GRF(1–29), without the drug affinity complex.
Their molecular identity, pharmacokinetics and research evidence should not be treated as interchangeable.
Atlas Longevity Pen Specifications
| Specification | Details |
|---|---|
| Product | CJC-1295 No DAC + Ipamorelin Blend |
| Brand | Atlas Longevity |
| Total Labelled Peptide Content | 20mg |
| CJC-1295 No DAC | 10mg |
| Ipamorelin | 10mg |
| Ingredient Ratio | 1:1 |
| Cartridge Volume | 3mL |
| Total Cartridge Units | 300 |
| Volume Per Unit | 0.01mL |
| Dial Range | 1–60 units |
| Maximum Dial Setting | 60 units |
| Format | Pre-mixed research peptide pen |
The Atlas Pen dial resets to zero after operation. Remaining cartridge contents stay in the pen.
Pre-Mixed Research Formulation
The Atlas Longevity CJC-1295 No DAC + Ipamorelin Pen is presented as a pre-mixed formulation.
The stability and compatibility of both peptides in one cartridge require appropriate formulation-specific testing.
A pre-filled pen format does not establish sterility or suitability for human injection.
Quality and Batch Documentation
Contact Atlas Longevity to request available batch-specific analytical documentation.
For combination products, appropriate testing should verify the identity and quantity of each peptide.
For CJC-1295 No DAC, analytical confirmation of the actual peptide sequence is particularly important because commercial naming can be inconsistent.
A purity Certificate of Analysis does not establish clinical safety, sterility or pharmaceutical approval.
Storage and Handling
Follow verified batch-specific storage instructions.
Protect from excessive heat, direct sunlight and contamination.
The stability and expiry of this pre-mixed combination should be supported by appropriate testing.
Safety Information
This combined formulation has not been adequately evaluated for human safety or effectiveness.
Potential risks associated with altering growth hormone signalling may include changes in glucose regulation, fluid balance and IGF-1 activity.
The adverse-effect profile and long-term risks of this specific combination remain inadequately characterised.
There is no established approved human dosing protocol for this blend.
Atlas Longevity Bali
Atlas Longevity provides information about experimental peptides, research specifications and available analytical documentation.
Contact our team for product information and regulatory enquiries.
Any supply must comply with applicable Indonesian regulations.
Frequently Asked Questions
What is CJC-1295 No DAC + Ipamorelin Blend?
It is an experimental combination of a GHRH-related peptide and a growth hormone secretagogue.
How much peptide is in the 20mg pen?
The pen is labelled as containing 10mg CJC-1295 No DAC and 10mg ipamorelin, giving a total of 20mg.
What is CJC-1295 No DAC?
CJC-1295 No DAC is commonly used as a commercial name for modified GRF(1–29), a peptide associated with GHRH receptor research.
What is Ipamorelin?
Ipamorelin is an experimental growth hormone secretagogue that acts through the GHS-R1a receptor.
What is the difference between CJC-1295 No DAC and CJC-1295 With DAC?
CJC-1295 with DAC contains a drug affinity complex, while products labelled No DAC generally refer to modified GRF(1–29). They should not be considered identical compounds.
Why are CJC-1295 No DAC and Ipamorelin combined?
They are associated with different receptor pathways involved in growth hormone signalling. This does not establish that the combination provides additional clinical benefits.
Does CJC-1295 No DAC + Ipamorelin increase growth hormone?
Both ingredients are associated with growth hormone-related research, but the response and safety of this specific combined formulation have not been adequately established.
Is this blend proven to improve muscle growth or fat loss?
No. There is insufficient high-quality clinical evidence to establish that this formulation improves muscle growth or fat loss.
How many units are in the Atlas Pen?
The Atlas Pen contains 300 volumetric units in a 3mL cartridge. Each unit represents 0.01mL.
Does the pen require mixing?
The product is presented as a pre-mixed research formulation, with no separate reconstitution step.
Is this blend approved for medical use?
No. This specific combination is not an established approved medical treatment.
Is this pen suitable for injection?
A pre-filled pen format or peptide purity result does not establish sterility, safety or suitability for human injection.
Is a Certificate of Analysis available?
Contact Atlas Longevity to request available batch-specific analytical documentation.
How should the pen be stored?
Follow the verified storage and expiry instructions for the specific formulation and batch.
Research Disclaimer
For laboratory research only. Not for human consumption or self-administration.
CJC-1295 No DAC and ipamorelin are experimental peptides. The safety, effectiveness and stability of this combined formulation have not been established for human administration.
This product is not intended to diagnose, treat, cure or prevent any disease.

Peptide Vials
Peptide Nasal Sprays
Peptide Protocols
Bundles